SPC202

Tríflúridín í samsetningu með tipiracíl eða salti af tipiracíl á borð við tipiracílhýdróklóríð

  • Status:
    Veitt
  • Application date:
    8.8.2017
  • Application published:
    15.9.2017
  • Grant published:
    15.2.2020
  • Max expiry date:
    24.1.2031
  • Next due date:
    31.1.2027
  • Medicine name:
    Lonsurf
  • Medicine for children:
    No

Timeline

Today
8.8.2017Application
15.9.2017Publication
15.2.2020Registration
24.1.2027Expires

Marketing license

  • IS authorization number:
    EU/1/16/1096/001-006
  • Date:
    25.5.2016
  • Foreign authorization number:
    EU/1/16/1096
  • Date:
    25.4.2016

Owner

  • Name:
    Taiho Pharmaceutical Co., Ltd.
  • Address:
    1-27 Kandanishiki-cho Chiyoda-ku, Tokyo JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 20.1.2026

Expires: 24.1.2027

Payer: Árnason Faktor ehf.

Upload documents